JCVI statement on mpox vaccination as a routine programme

This statement provides Joint Committee on Vaccination and Immunisation (JCVI) advice on the
Modified Vaccinia Ankara – Bavarian Nordic (MVA-BN) vaccine for the prevention of mpox in terms
of programme cost-effectiveness and likely impact on epidemiology.